6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow proteomic profiling: new trials by email Literature Review of proteomic profiling trials Research Report on proteomic profiling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer bevacizumab, carboplatin, erlotinib hydrochloride - Lung Cancer | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 116 | 2007-10-01 | 2017-06-08 |
| Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery gemcitabine hydrochloride, oxaliplatin, protein expression analysis - Pancreatic Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 39 | 2007-10-01 | 2017-03-16 |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer bevacizumab, cisplatin, irinotecan hydrochloride - Esophageal Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 34 | 2006-04-01 | 2016-05-16 |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors capecitabine, cisplatin, streptozocin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 84 | 2005-08-01 | 2013-08-07 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery gemcitabine hydrochloride, floxuridine, proteomic profiling - Liver Metastases, Recurrent Colon Cancer | Phase 1 / Phase 2 | Completed | City of Hope Medical Center | 16 | 2005-06-13 | 2026-11-03 |
| Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery cetuximab, celecoxib, proteomic profiling - Colorectal Cancer | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 17 | 2005-05-01 | 2012-12-19 |
Colonic Neoplasms (2) · Rectal Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Gastrinoma (1) · Glucagonoma (1) · Insulinoma (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1)
Memorial Sloan Kettering Cancer Center (2) · Vanderbilt-Ingram Cancer Center (2) · Cambridge University Hospitals NHS Foundation Trust (1) · City of Hope Medical Center (1)
United States (5) · United Kingdom (1)
David Carbone, M.D., Ph.D. (1) · David H. Ilson, MD, PhD (1) · Eileen O'Reilly, MD (1) · Jeffrey Wong (1) · Jordan D. Berlin, MD (1) · Peter J. Allen, MD (1) · Pippa Corrie, PhD, FRCP (1) · Tim Meyer, MD, BSc, MRCP, PhD (1)
P30CA068485 (2), P30CA008748 (1)